Introduction
The Current Intervention
Study Aims and Hypotheses
Method
Setting, Participants and Procedure
Measures
Description of Intervention
Lesson | Skills overview |
---|---|
1 | Psychoeducation about rumination and worry |
Self-monitoring of rumination/worry | |
Activity Planning for “high risk” times | |
2 | Three Rules of Thumb to differentiate helpful vs unhelpful rumination/worry |
Structured Problem Solving | |
Worry Time | |
Disengaging from rumination/worry by Shifting Attention onto present moment | |
3 | Managing Rumination and Worry at Night |
Shifting from General to Specific Thinking | |
Summary of program content and relapse prevention |
Statistical Analyses
Results
Pattern of Symptom Change Across Treatment
Measure | Group | Baseline (Pre-Lesson 1) | Lesson 2 | Lesson 3 | Post-treatment | 3-Month follow-up | L1-L2 | L2-L3 | L3-Post | Post-FU | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EMM | SD | EMM | SD | EMM | SD | EMM | SD | EMM | SD | Hedges g (95% CI) | Hedges g (95% CI) | Hedges g (95% CI) | Hedges g (95% CI) | ||
RTQ-10 | Clinician guided | 38.67 | 7.30 | 36.57 | 7.65 | 33.04 | 8.11 | 28.39 | 8.03 | 25.48 | 8.47 | 0.28 (-0.16, 0.72) | 0.44 (-0.04, 0.92) | 0.57 (0.08, 1.05)* | 0.35 (-0.16, 0.86) |
Self-help | 41.06 | 7.30 | 38.63 | 7.49 | 35.03 | 7.80 | 31.71 | 7.95 | 32.58 | 8.18 | 0.33 (-0.09, 0.75) | 0.47 (0.02, 0.92)* | 0.42 (-0.04, 0.88) | 0.11 (-0.37, 0.58) | |
K-10 | Clinician guided | 23.93 | 7.45 | 22.71 | 7.63 | 20.35 | 7.85 | 18.25 | 7.81 | 17.15 | 8.02 | 0.16 (-0.28, 0.60) | 0.30 (-0.18, 0.78) | 0.27 (-0.21, 0.74) | 0.14 (-0.37, 0.64) |
Self-help | 27.30 | 7.45 | 25.25 | 7.55 | 24.76 | 7.69 | 23.12 | 7.76 | 22.12 | 7.90 | 0.27 (-0.15, 0.69) | 0.06 (-0.38, 0.51) | 0.21 (-0.25, 0.67) | 0.13 (-0.36, 0.61) |
Measure | Group | Baseline (Pre-Lesson 1) | Lesson 2 | Lesson 3 | Post-treatment | 3-Month Follow-Up | L1-L2 | L2-L3 | L3-Post | Post-FU | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EMM | SD | EMM | SD | EMM | SD | EMM | SD | EMM | SD | Hedges g (95% CI) | Hedges g (95% CI) | Hedges g (95% CI) | Hedges g (95% CI) | ||
RTQ-10 | Clinician guided | 38.88 | 7.49 | 36.77 | 7.78 | 33.20 | 8.26 | 28.56 | 8.19 | 25.65 | 8.63 | 0.27 (-0.17, 0.71) | 0.44 (-0.04, 0.92) | 0.56 (0.07, 1.04)* | 0.34 (-0.17, 0.85) |
Self-help | 40.61 | 6.90 | 38.18 | 7.10 | 34.56 | 7.42 | 31.27 | 7.56 | 32.14 | 7.79 | 0.34 (-0.08, 0.77) | 0.49 (0.04, 0.94)* | 0.43 (-0.03, 0.90) | 0.11 (-0.36, 0.59) | |
K-10 | Clinician guided | 25.12 | 5.31 | 23.90 | 5.49 | 21.41 | 5.80 | 19.35 | 5.75 | 18.13 | 6.02 | 0.22 (-0.22, 0.66) | 0.44 (-0.04, 0.92) | 0.35 (-0.13, 0.83) | 0.20 (-0.30, 0.71) |
Self-help | 26.33 | 4.85 | 24.28 | 4.98 | 23.77 | 5.18 | 22.11 | 5.27 | 21.03 | 5.47 | 0.41 (-0.01, 0.84) | 0.10 (-0.34, 0.54) | 0.31 (-0.14, 0.77) | 0.20 (-0.28, 0.68) |
Mediating Effect of RNT
Lesson-By-Lesson Mediation
Mediating Effect of RNT on Distress
Time | Group | Indirect effect | Proportion of total effect mediated |
---|---|---|---|
β (95% CI) | |||
Lessons 1-2 | Overall | 0.036 (-0.02– 0.10) | 0.582 |
Clinician-guided | 0.014 (-0.08– 0.11) | 0.065 | |
Self-help | 0.05 (-0.01– 0.12) | 0.627 | |
Lessons 2-3 | Overall | 0.08 (0.02—0.14) * | 1.85 |
Clinician-guided | 0.13 (0.03—0.25) * | 2.41 | |
Self-help | 0.05 (-0.04– 0.15) | 0.91 | |
Lesson 3-Post | Overall | 0.02 (-0.06– 0.10) | 0.07 |
Clinician-guided | 0.03 (-0.03– 0.13) | 0.09 | |
Self-help | 0.01 (-0.14– 0.14) | 0.03 |
Mediating effect of distress on RNT
Time | Group | Indirect effect | Proportion of total effect mediated |
---|---|---|---|
β (95% CI) | |||
Lessons 1—2 | Overall | 0.04 (− 0.03– 0.13) | 0.137 |
Clinician-guided | 0.07 (− 0.05– 0.23) | 0.192 | |
Self-help | 0.02 (− 0.08– 0.11) | 0.057 | |
Lessons 2—3 | Overall | 0.02 (− 0.12– 0.16) | 0.066 |
Clinician-guided | − 0.03 (− 0.19– 0.09) | 0.278 | |
Self-help | 0.13 (-0.08– 0.39) | 0.291 | |
Lesson 3—Post | Overall | − 0.02 (− 0.13– 0.09) | 0.084 |
Clinician-guided | − 0.08 (− 0.21– 0.003) | 0.569 | |
Self-help | 0.03 (− 0.21– 0.27) | 0.104 |
Pre- to Post and Follow-Up Mediation
Mediating Effect of RNT
Time | Group | Depression (PHQ-9) | Anxiety (GAD-7) | Distress (K-10) | |||
---|---|---|---|---|---|---|---|
Indirect effect | Total effect mediated | Indirect effect | Total effect mediated | Indirect effect | Total effect mediated | ||
β (95% CI) | Proportion | β (95% CI) | Proportion | β (95% CI) | Proportion | ||
Pre-Post | Overall | 0.03 (− 0.03– 0.09) | 0.04 | 0.08 (− 0.02– 0.19) | 0.14 | 0.02 (− 0.06– 0.09) | 0.03 |
Clinician-guided | 0.002 (− 0.08– 0.08) | 0.01 | 0.03 (− 0.08– 0.15) | 0.09 | 0.01 (− 0.12– 0.14) | 0.01 | |
Self-help | 0.01 (− 0.07– 0.11) | 0.02 | 0.02 (− 0.22– 0.25) | 0.04 | 0.004 (− 0.12– 0.13) | 0.01 | |
Post-FU | Overall | 0.06 (0.01– 0.13)* | 0.07 | 0.04 (− 0.03– 0.12) | 0.05 | 0.06 (0.00– 0.13) | 0.07 |
Clinician | 0.02 (− 0.05– 0.13) | 0.04 | 0.01 (− 0.07– 0.09) | 0.02 | 0.04 (− 0.09– 0.24) | 0.07 | |
Self-help | 0.02 (− 0.02– 0.07) | 0.02 | 0.09 (− 0.06– 0.35) | 0.12 | 0.04 (− 0.04– 0.18) | 0.06 |
Mediating Effect of Worry
Time | Group | Depression (PHQ9) | Anxiety (GAD7) | Distress (K10) | |||
---|---|---|---|---|---|---|---|
Indirect effect | Total effect mediated | Indirect effect | Total effect mediated | Indirect effect | Total effect mediated | ||
β (95% CI) | Proportion | β (95% CI) | Proportion | β (95% CI) | Proportion | ||
Pre-Post | Overall | 0.004 (− 0.04– 0.05) | 0.01 | 0.10 (− 0.004– 0.22) | 0.141 | 0.03 (− 0.02– 0.10) | 0.04 |
Clinician-guided | 0.01 (− 0.03– 0.06) | .026 | 0.07 (− 0.004– 0.17) | 0.169 | 0.04 (− 0.03– 0.12) | 0.07 | |
Self-help | 0.03 (− 0.04– 0.12) | .037 | 0.02 (− 0.13– 0.19) | 0.04 | 0.05 (− 0.07– 0.17) | 0.054 | |
Post-FU | Overall | 0.04 (− 0.001– 0.09) | 0.04 | 0.07 (− 0.001– 0.16) | 0.087 | 0.04 (− 0.01– 0.11) | 0.057 |
Clinician-guided | 0.01 (− 0.06– 0.09) | 0.01 | 0.01 (− 0.08– 0.11) | 0.033 | 0.02 (− 0.07– 0.16) | 0.039 | |
Self-help | 0.01 (− 0.03– 0.06) | 0.01 | 0.01 (− 0.12– 0.15) | 0.008 | 0.01 (− 0.06– 0.09) | 0.009 |
Mediating Effect of Rumination
Time | Group | Depression (PHQ9) | Anxiety (GAD7) | Distress (K10) | |||
---|---|---|---|---|---|---|---|
Indirect effect | Total effect mediated | Indirect effect | Total effect mediated | Indirect effect | Total effect mediated | ||
β (95% CI) | Proportion | β (95% CI) | Proportion | β (95% CI) | Proportion | ||
Pre-Post | Overall | 0.01 (− 0.04– 0.06) | 0.015 | − 0.001 (− 0.08– 0.08) | 0.001 | 0.01 (− 0.03– 0.06) | 0.012 |
Clinician-guided | 0.04 (− 0.002– 0.10) | 0.084 | 0.02 (− 0.06– 0.10) | 0.043 | 0.04 (− 0.01– 0.11) | 0.08 | |
Self-help | − 0.04 (− 0.17– 0.06) | 0.056 | − 0.11 (− 0.30– 0.02) | 0.228 | − 0.13 (− 0.29—0.01) | 0.157 | |
Post-FU | Overall | 0.07 (− 0.002– 0.13) | 0.072 | 0.02 (− 0.02– 0.08) | 0.025 | 0.07 (0.01– 0.14)* | 0.079 |
Clinician-guided | 0.001 (− 0.04– 0.04) | 0.002 | − 0.01 (− 0.07– 0.04) | 0.039 | − 0.001 (− 0.04– 0.04) | 0.001 | |
Self-help | 0.15 (0.05– 0.29)* | 0.155 | 0.15 (− 0.004– 0.35) | 0.174 | 0.24 (0.11– 0.40)** | 0.313 |
Predictors of Treatment Response
Estimate | SE | df | T | p | 95% Confidence Interval | ||
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
DV = PHQ-9 | |||||||
Intercept | 0.74 | 2.07 | 90.54 | 0.36 | 0.72 | − 3.37 | 4.85 |
Pre | 3.82 | 0.41 | 163.15 | 9.39 | < 0.001** | 3.02 | 4.63 |
Post | 0.42 | 0.43 | 155.21 | 1.00 | 0.32 | − 0.42 | 1.27 |
Follow-up | 0.00 | 0.00 | |||||
Clinician-guided | − 0.59 | 0.39 | 86.48 | − 1.49 | 0.14 | − 1.37 | 0.19 |
Self-guided | 0.00 | 0.00 | |||||
CEQ | − 0.15 | 0.04 | 88.94 | − 3.47 | < 0.001** | − 0.24 | − 0.06 |
RTQ | 0.02 | 0.04 | 87.90 | 0.50 | 0.62 | − 0.06 | 0.10 |
PHQ-9 | 0.70 | 0.05 | 80.98 | 15.61 | < 0.001** | 0.61 | 0.79 |
GAD-7 | − 0.03 | 0.05 | 92.76 | − 0.55 | 0.58 | − 0.14 | 0.08 |
PSWQ | 0.00 | 0.03 | 99.86 | 0.18 | 0.86 | − 0.05 | 0.06 |
RRS-Brooding | 0.17 | 0.07 | 81.85 | 2.41 | 0.02* | 0.03 | 0.31 |
DV = GAD-7 | |||||||
Intercept | 1.62 | 2.18 | 216.00 | 0.74 | 0.46 | − 2.69 | 5.92 |
Pre | 4.68 | 0.48 | 216.00 | 9.76 | < 0.001** | 3.74 | 5.63 |
Post | 0.39 | 0.50 | 216.00 | 0.78 | 0.43 | − 0.60 | 1.39 |
Follow-up | 0.00 | 0.00 | |||||
Clinician-guided | − 1.31 | 0.41 | 216.00 | − 3.16 | < 0.001** | − 2.13 | − 0.49 |
Self-guided | 0.00 | 0.00 | |||||
CEQ | − 0.10 | 0.05 | 216.00 | − 2.14 | 0.03* | − 0.19 | − 0.01 |
RTQ | 0.02 | 0.04 | 216.00 | 0.57 | 0.57 | − 0.06 | 0.11 |
PHQ-9 | 0.02 | 0.05 | 216.00 | 0.42 | 0.67 | − 0.07 | 0.11 |
GAD-7 | 0.64 | 0.06 | 216.00 | 11.23 | < 0.001** | 0.52 | 0.75 |
PSWQ | − 0.03 | 0.03 | 216.00 | − 1.02 | 0.31 | − 0.09 | 0.03 |
RRS-Brooding | 0.14 | 0.07 | 216.00 | 1.95 | 0.05 | 0.00 | 0.29 |
Estimate | SE | df | T | P | 95% Confidence Interval | ||
---|---|---|---|---|---|---|---|
Lower | Upper | ||||||
DV = RTQ-10 | |||||||
Intercept | 9.89 | 5.26 | 94.55 | 1.88 | 0.06 | − 0.55 | 20.33 |
Pre | 10.45 | 0.94 | 165.21 | 11.06 | < 0.001** | 8.58 | 12.31 |
Post | 0.87 | 0.99 | 157.28 | 0.88 | 0.38 | − 1.08 | 2.82 |
Follow-up | 0.00 | 0.00 | |||||
Clinician-guided | − 1.41 | 1.01 | 92.94 | − 1.39 | 0.17 | − 3.41 | 0.60 |
Self-guided | 0.00 | 0.00 | |||||
CEQ | − 0.27 | 0.11 | 93.58 | − 2.43 | 0.02* | − 0.49 | − 0.05 |
RTQ | 0.59 | 0.10 | 93.97 | 5.78 | < 0.001** | 0.38 | 0.79 |
PHQ-9 | 0.10 | 0.12 | 87.62 | 0.85 | 0.40 | − 0.13 | 0.33 |
GAD-7 | − 0.05 | 0.14 | 99.03 | − 0.36 | 0.72 | − 0.32 | 0.22 |
PSWQ | 0.00 | 0.07 | 104.89 | − 0.02 | 0.99 | − 0.14 | 0.14 |
RRS-Brooding | 0.31 | 0.18 | 88.29 | 1.72 | 0.09 | − 0.05 | 0.66 |
DV = PSWQ | |||||||
Intercept | 15.35 | 6.04 | 94.44 | 2.54 | 0.01* | 3.36 | 27.34 |
Pre | 10.70 | 1.10 | 163.95 | 9.72 | < 0.01** | 8.53 | 12.88 |
Post | 2.24 | 1.15 | 155.06 | 1.95 | 0.05 | − 0.02 | 4.51 |
Follow-up | 0.00 | 0.00 | |||||
Clinician-guided | − 1.57 | 1.15 | 91.08 | − 1.36 | 0.18 | − 3.86 | 0.72 |
Self-guided | 0.00 | 0.00 | |||||
CEQ | − 0.31 | 0.13 | 93.43 | − 2.44 | 0.02* | − 0.56 | − 0.06 |
RTQ | − 0.04 | 0.12 | 92.16 | − 0.36 | 0.72 | − 0.27 | 0.19 |
PHQ-9 | − 0.05 | 0.13 | 86.30 | − 0.36 | 0.72 | − 0.31 | 0.22 |
GAD-7 | 0.10 | 0.16 | 97.16 | 0.66 | 0.51 | − 0.21 | 0.41 |
PSWQ | 0.70 | 0.08 | 103.33 | 8.80 | < 0.001** | 0.54 | 0.86 |
RRS-Brooding | 0.27 | 0.20 | 86.55 | 1.35 | 0.18 | − 0.13 | 0.68 |
DV = RRS-Brooding | |||||||
Intercept | 0.79 | 1.54 | 94.03 | 0.51 | 0.61 | − 2.27 | 3.85 |
Pre | 2.64 | 0.30 | 165.32 | 8.88 | < 0.001** | 2.05 | 3.22 |
Post | 0.78 | 0.31 | 156.36 | 2.53 | 0.01* | 0.17 | 1.40 |
Follow-up | 0.00 | 0.00 | |||||
Clinician-guided | − 0.47 | 0.29 | 90.22 | − 1.59 | 0.12 | − 1.05 | 0.12 |
Self-guided | 0.00 | 0.00 | |||||
CEQ | − 0.08 | 0.03 | 92.63 | − 2.58 | 0.01* | − 0.15 | − 0.02 |
RTQ | 0.00 | 0.03 | 91.54 | − 0.11 | 0.91 | − 0.06 | 0.06 |
PHQ-9 | 0.05 | 0.03 | 85.16 | 1.40 | 0.17 | − 0.02 | 0.11 |
GAD-7 | − 0.02 | 0.04 | 96.47 | − 0.57 | 0.57 | − 0.10 | 0.06 |
PSWQ | 0.00 | 0.02 | 103.25 | 0.23 | 0.82 | − 0.04 | 0.05 |
RRS-Brooding | 0.80 | 0.05 | 85.54 | 15.51 | < 0.001** | 0.70 | 0.91 |